Onco-Innovations’ (CBOE CA:ONCO) wholly-owned subsidiary, Inka Health Corp., has received a formal Expression of Interest (EOI) from AstraZeneca (NASDAQ:AZN) to participate as a founding member in the ...

wants to advance AI methodologies to improve predictive modeling in oncology ・AstraZeneca’s EOI could mark a significant step toward establishing a multi-stakeholder platform focused on enhancing the ...